Abstract

Chest pain is a common cause of presentation to the Acute Medical Unit and the use of cardiac stress imaging in these patients is becoming more widespread. This article aims to provide Acute Physicians with a basic understanding of the different modalities and how to select a particular test for a given patient.
[download-attachments container="div" style="list" dipslay_icon="1" display_count="1" display__size="0"]

References

1. Sanchis J, Bodi V, Llacer A et al. Risk stratification of patients with acute chest pain and normal troponin concentrations. Heart 2005; 91: 1013–1018.
2. Cerqueira MD, Verani MS, Schwaiger M et al. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol 1994; 23: 384–9.
3. Geleijnse ML, Fioretti PM & Roelandt JRTC. Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol 1997; 30(3): 595–606.
4. Allman KC, Shaw LJ, Hachamovitch R et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction, a meta-analysis. J Am Coll Cardiol 2002; 39: 1151–8.
5. Cornel JH, Bax JJ, Elhendy A et al. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: implications of time course of recovery on diagnostic accuracy. J Am Coll Cardiol 1998; 31: 1002–10.
6. Dolan MS, Riad K, El-Shafei A et al. Effect of intravenous contrast for left ventricular opacification and border definition on sensitivity and specificity of dobutamine stress echocardiography compared with coronary angiography in technically difficult patients. Am Heart J 2001; 38: 117–123.
7. Klem I, Heitner JF, Shah DJ et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol 2004; 47(8): 1630–8.
8. Underwood SR, Anagnostopoulos C, Cerqueria et al. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging 2004; 31: 261–91.
9. Schujif JD, Shaw LJ, Wijns W et al. Cardiac imaging in coronary artery disease: differing modalities. Heart 2005; 91: 1110–7.
10. Nandalur KR, Dwamena BA, Choudri AF et al. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease. A meta-analysis. J Am Coll Cardiol 2007; 50(14): 1343–53.
11. Metz LD, Beattie M, Hom R et al. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: A meta-analysis. J Am Coll Cardiol 2007; 49: 227–237.
12. Jahnke C, Nagel E, Gebker R et al. Prognostic value of cardiac magnetic resonance stress tests. Adenosine stress perfusion and dobutamine stress wall motion imaging. Circ 2007; 115(3): 1769–1776.
13. Underwood SR, Bax JJ, vom Dahl J et al. Imaging techniques for the assessment of myocardial hibernation. Report of a study group of the European Society of Cardiology. Eur Heart J 2004; 25(10): 815–836.